Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP

Fig. 5

Longitudinal linear mixed-effects model analyses evaluating the relationship between PET tracers’ binding/uptake and plasma GFAP. (A, B) Scatterplots for composite cortical ROIs and (C, D) surface maps where cortical ROIs with a significant longitudinal association between PET tracers’ binding/uptake and plasma GFAP are depicted in colour. The estimate (Est.), the standard error (parentheses) and p value of the models are shown. NC: non-carriers; pMC: presymptomatic mutation carriers; sMC: symptomatic mutation carriers

Back to article page

Molecular Neurodegeneration

ISSN: 1750-1326